Skip to main content
Voting Is Now Open for 2024–2025 U.S. News & World Report Best Hospitals Learn How

Physician Resources

Recently Added |view more

Mapping a Path to Clinical Trials: Bringing Fox Chase’s Innovative Care to the Temple Community News

Mapping a Path to Clinical Trials: Bringing Fox Chase’s Innovative Care to the Temple Community

Clinical trials are among the most important resources when it comes to effectively treating challenging cases of cancer, but at Fox Chase Cancer Center, these trials encompass much more than just testing new drug candidates that may be ...

2024 Atlantic Regional Hematopathology Meeting Course

2024 Atlantic Regional Hematopathology Meeting

Advancements in hematopathology based on molecular and genetic information are rapidly evolving, making it challenging to keep up with the latest developments and their implications for diagnosis and therapy. This meeting will focus on ...

Benign Prostatic Hyperplasia News

Benign Prostatic Hyperplasia

With one of the largest and most experienced urology teams in the region and the latest treatment capabilities, the Fox Chase-Temple Urologic Institute is a trusted leader in treating all types of urologic conditions.

Fox Chase-Temple Urologic Institute: The Next Generation of Urology Care News

Fox Chase-Temple Urologic Institute: The Next Generation of Urology Care

Our innovative partnership unites the expertise of distinguished institutions within one health system, allowing us to tackle the most challenging genitourinary malignancies as well as complex benign urologic conditions.

Fox Chase Welcomes Leukemia Specialist Sara Small, MD, PhD News

Fox Chase Welcomes Leukemia Specialist Sara Small, MD, PhD

Sara Small, MD, PhD, assistant professor in the Department of Bone Marrow Transplant and Cellular Therapies.

TAS1440 +/- All-Trans Retinoic Acid (ATRA) in Relapsed/Refractory AML News

TAS1440 +/- All-Trans Retinoic Acid (ATRA) in Relapsed/Refractory AML

A first of its kind, Phase 1 multi-center study for Relapsed or Refractory Acute Myeloid Leukemia using an investigational drug TAS1440 by itself, and in combination with All-Trans Retinoic Acid (ATRA).

Key Takeaways from 2023 American Society of Hematology Meeting News

Key Takeaways from 2023 American Society of Hematology Meeting

Fox Chase Physician Demonstrates Safety and Effectiveness of Myeloma Drug for Black or African American Patients

Celebrating 35 years of the Fox Chase-Temple University Hospital Bone Marrow Transplant Program News

Celebrating 35 years of the Fox Chase-Temple University Hospital Bone Marrow Transplant Program

One of the truly gratifying truths about cancer care is the amazing progress we have made in just the last few decades.